Director, Early Clinical Development (MD) – Hematology & Cell Therapy at Bristol-Myers Squibb

Brisbane, California, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

MD (physician-scientist or clinical-scientist background implied)
Expertise in early clinical development, particularly Phase I/II studies in hematology, cell therapy, and autoimmune indications (hematology, rheumatology, neurology)
Demonstrated decision-making capabilities in managing clinical trials
Ability to provide medical and scientific expertise to cross-functional teams
Experience in matrix management across internal and external networks
Knowledge of GCP and compliance obligations for clinical conduct
Maintains all required training

Responsibilities

Serves as primary source of medical accountability and oversight for multiple clinical trials
Manages Phase I/II studies from Phase 1 through Proof-of-Concept
Acts as independent medical monitor: articulates clinical development strategy, analyzes/interprets/acts on clinical trial data, serves as principal functional author for regulatory submissions, study reports, and publications
Provides oversight and medical accountability for multiple trials across early development lifecycle
Manages site interactions in partnership with Clinical Scientist for medical questions, education, and safety management
Assesses key safety-related serious adverse events in partnership with Worldwide Patient Safety and oversees safety narratives
Contributes to and is a key member of high-performing Study Delivery Team (SDT) and may be a member of the Development Team
Collaborates with Clinical Scientist and provides input into protocols, including medical strategic oversight on inclusion/exclusion and safety considerations
Designs and develops clinical studies and research plans in support of asset strategy
Provides medical and scientific expertise to cross-functional BMS colleagues
Maintains matrix management responsibilities across internal and external networks
Acts as focal point for defining and establishing relationships with key global Phase I Centers
Works on multiple trials across early development clinical lifecycle

Skills

Clinical Development

Cellular Therapy

Autoimmune Disorders

Hematology

Rheumatology

Neurology

Biomarkers

Patient Enrichment

Dosing Strategies

Translational Medicine

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free